Adenocarcinoma of the Pancreas Terminated Phase 2 Trials for Paclitaxel (DB01229)

Also known as: Adenocarcinoma, Pancreatic / Adenocarcinoma of Pancreas / Pancreas Adenocarcinoma / Adenocarcinoma, Pancreas / Pancreatic Adenocarcinoma / Pancreas, Adenocarcinoma / Adenocarcinoma Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02124369Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE)Treatment
NCT01921751High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by SurgeryTreatment